Cargando…
Antibody therapies for melanoma: New and emerging opportunities to activate immunity (Review)
The interface between malignant melanoma and patient immunity has long been recognised and efforts to treat this most lethal form of skin cancer by activating immune responses with cytokine, vaccine and also antibody immunotherapies have demonstrated promise in limited subsets of patients. In the pr...
Autores principales: | MALAS, SADEK, HARRASSER, MICAELA, LACY, KATIE E., KARAGIANNIS, SOPHIA N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4121424/ https://www.ncbi.nlm.nih.gov/pubmed/24969320 http://dx.doi.org/10.3892/or.2014.3275 |
Ejemplares similares
-
Chemokine Pathways in Cutaneous Melanoma: Their Modulation by Cancer and Exploitation by the Clinician
por: Adams, Rebecca, et al.
Publicado: (2021) -
Influencing tumor-associated macrophages in malignant melanoma with monoclonal antibodies
por: Adams, Rebecca, et al.
Publicado: (2022) -
B cells and the humoral response in melanoma: The overlooked players of the tumor microenvironment
por: Chiaruttini, Giulia, et al.
Publicado: (2017) -
Immune cell–antibody interactions in health and disease
por: Karagiannis, Sophia N, et al.
Publicado: (2022) -
Evaluating Biomarkers in Melanoma
por: Karagiannis, Panagiotis, et al.
Publicado: (2015)